ATE435848T1 - Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q - Google Patents

Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q

Info

Publication number
ATE435848T1
ATE435848T1 AT02775312T AT02775312T ATE435848T1 AT E435848 T1 ATE435848 T1 AT E435848T1 AT 02775312 T AT02775312 T AT 02775312T AT 02775312 T AT02775312 T AT 02775312T AT E435848 T1 ATE435848 T1 AT E435848T1
Authority
AT
Austria
Prior art keywords
reduced coenzyme
aqueous solution
stabilized compositions
present
solution containing
Prior art date
Application number
AT02775312T
Other languages
English (en)
Inventor
Kenji Fujii
Taizo Kawabe
Kazunori Hosoe
Takayoshi Hidaka
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of ATE435848T1 publication Critical patent/ATE435848T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
AT02775312T 2001-10-10 2002-10-10 Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q ATE435848T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001312181A JP3822479B2 (ja) 2001-10-10 2001-10-10 還元型補酵素ｑ水溶液の安定化組成
PCT/JP2002/010516 WO2003033445A1 (fr) 2001-10-10 2002-10-10 Compositions stabilisees de solution de coenzyme q reduite aqueuse

Publications (1)

Publication Number Publication Date
ATE435848T1 true ATE435848T1 (de) 2009-07-15

Family

ID=19130880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02775312T ATE435848T1 (de) 2001-10-10 2002-10-10 Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q

Country Status (10)

Country Link
US (1) US7364751B2 (de)
EP (1) EP1440962B1 (de)
JP (1) JP3822479B2 (de)
KR (1) KR20050035127A (de)
CN (2) CN1297527C (de)
AT (1) ATE435848T1 (de)
CA (1) CA2461550A1 (de)
DE (1) DE60232903D1 (de)
TW (1) TWI245628B (de)
WO (1) WO2003033445A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329510B (en) 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10
TWI349039B (en) 2001-12-27 2011-09-21 Kaneka Corp Processes for producing coenzyme q10
TW200302056A (en) * 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
TW200304372A (en) * 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Compositions for diabetes
CN1870982B (zh) * 2003-10-31 2010-05-26 株式会社钟化 含还原型辅酶q的组合物
TW200524579A (en) * 2003-11-28 2005-08-01 Kaneka Corp Composition for protecting liver functions
JP5243718B2 (ja) * 2004-04-09 2013-07-24 株式会社カネカ 還元型補酵素ｑ１０およびカロチノイド類を含有した組成物
RU2007128342A (ru) * 2004-12-24 2009-01-27 Канека Корпорейшн (Jp) Твердый препарат, содержащий восстановленный кофермент q10 и способ его продуцирования
TW200722076A (en) * 2005-03-29 2007-06-16 Kaneka Corp Composition for increasing anti-oxidation activity in blood
EP2005949A1 (de) * 2006-03-13 2008-12-24 Kaneka Corporation Mittel zur linderung von herzfunktionsstörungen oder mittel zur aufrechterhaltung der herzfunktion
CA2662607A1 (en) * 2006-09-08 2008-03-13 Kaneka Corporation Composition comprising reduced coenzyme q10 and lysolecithin
DK200800040U3 (da) 2008-03-06 2009-06-26 Pharma Nord Aps Lægemiddel og kosttilskud med indhold af stabiliseret ubiquinol i beskyttende pakning.
CN101307338B (zh) * 2008-07-17 2012-04-25 任雷 还原型辅酶q10的制备方法
WO2011045934A1 (ja) * 2009-10-16 2011-04-21 株式会社カネカ 還元型補酵素ｑ１０の製造方法、安定化方法及びそれを含有する組成物
JP2011160746A (ja) * 2010-02-12 2011-08-25 Sanei Gen Ffi Inc ユビキノール含有透明容器入り飲料
CN102247301A (zh) * 2010-05-21 2011-11-23 上海新都生物科技有限公司 还原型辅酶q10的用途及在化妆品中的使用方法
CN101912371B (zh) * 2010-08-30 2012-11-14 熊军 含有辅酶q10的注射剂组合物及其制备方法
CN104738620A (zh) * 2015-03-06 2015-07-01 江南大学 一种还原型辅酶q10的纳米脂质体组合物及其制备方法
TWI754659B (zh) * 2016-08-08 2022-02-11 台灣微脂體股份有限公司 用於製備含有弱酸性劑之微脂體組合物的傳輸載體、方法及套組
CN110496103B (zh) * 2018-05-18 2022-05-10 上海维洱生物医药科技有限公司 一种多西他赛棕榈酸酯脂质体及其制备方法
US11471426B2 (en) 2019-10-16 2022-10-18 American River Nutrition, Llc Compositions comprising quinone and/or quinol and methods of preparations and use thereof
WO2021176264A1 (en) * 2020-03-02 2021-09-10 Yogesh Dound Liposomal compositions and process for preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54119424A (en) * 1978-03-08 1979-09-17 Ajinomoto Co Inc Preparation of dihydrocoenzyme q analog
IT1250672B (it) 1991-07-11 1995-04-21 Idb Holding Spa Formulazioni orali di ubidecarenone in soluzione acquosa
JPH08502300A (ja) 1992-10-14 1996-03-12 スターリング ウィンスロップ アイエヌシー． 治療および診断像形成組成物および方法
IT1263840B (it) 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
US5891465A (en) 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
JP3926888B2 (ja) * 1997-05-27 2007-06-06 株式会社カネカ コレステロール低下剤
US6066327A (en) * 1997-12-17 2000-05-23 Color Access, Inc. Antioxidant mixture
JP3080162B2 (ja) 1998-01-27 2000-08-21 日本パーカライジング株式会社 酸化チタンゾルおよびその製造方法
US6045826A (en) 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
JP3542305B2 (ja) 1999-07-07 2004-07-14 小林製薬株式会社 徐溶性ゲル状組成物
US8753675B1 (en) 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6740338B1 (en) * 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
GB0017060D0 (en) * 2000-07-11 2000-08-30 Hunter Fleming Ltd Production, stabilisation and use of reduced forms of pharmaceutical compounds
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
TWI310029B (de) 2001-07-13 2009-05-21 Kaneka Corp
TWI329510B (en) 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10

Also Published As

Publication number Publication date
JP2003119126A (ja) 2003-04-23
DE60232903D1 (de) 2009-08-20
WO2003033445A1 (fr) 2003-04-24
CN1899272A (zh) 2007-01-24
EP1440962A4 (de) 2007-10-31
CN1564796A (zh) 2005-01-12
CA2461550A1 (en) 2003-04-24
JP3822479B2 (ja) 2006-09-20
CN1297527C (zh) 2007-01-31
EP1440962B1 (de) 2009-07-08
EP1440962A1 (de) 2004-07-28
US20050070481A1 (en) 2005-03-31
US7364751B2 (en) 2008-04-29
TWI245628B (en) 2005-12-21
KR20050035127A (ko) 2005-04-15

Similar Documents

Publication Publication Date Title
DE60232903D1 (de) Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q
GB0100610D0 (en) Improvements in or relating to organic compounds
SI1392642T1 (sl) Nove spojine kot protivnetna, imunomodulacijska in antiproliferativna sredstva
DK1301077T3 (da) Antimikrobielt præparat, som er nyttigt til behandling af bovin mastitis
DE60235900D1 (de) Osuppressivum
SG114563A1 (en) Microbicidal and algicidal composition, microbicidal and algicidal process for a water system and process for producing a microbicidal and algicidal comosition
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
EP1126317A3 (de) Mehrteilige photographische Farbentwicklerzusammensetzung und Verfahren zu ihrer Herstellung sowie ihre Verwendung
NO20024239D0 (no) Fremgangsmåte ved oksidasjon av en tioetergruppe til en sulfoksidgruppe
AR035420A1 (es) Un proceso para la preparacion de un compuesto imidazo-tetrazin-4-ona y un proceso para la preparacion de la temozolomida e intermediarios
HUP0400520A2 (hu) Klindamicint és cinksót tartalmazó dermatológiai készítmények
DK1327453T3 (da) Stabile taurolidinelektrolytoplösninger
ES2015529B3 (es) Composicion de peroxidicarbonato estabilizado
DK0654470T3 (da) Lagerstabile vandige opløsninger af isothiazolin-3-oner
MX2007008468A (es) Preparaciones solidas antimicrobianas.
FR2827169B1 (fr) Durcisseur pour les ongles
BR0003166A (pt) Processo para estabilização de compostos antioxidantes, e composições aquosas
DK1381397T3 (da) Stabilisering af radiofarmaceutiske præparater ved anvendelse af hydrofile thioethere
AU2002342498A1 (en) Organic compounds
DE60123030D1 (de) Stabilisierung von hochsensitiven nukleinsäurefärbungen in wässriger lösung
DE60026292D1 (de) Eine stabilisierte isothiazolon-zusammensetzung und ein verfahren zur stabilisierung von isothiazolon
EP1269976A3 (de) Mittel zum Blondieren von menschlichen Haaren
ATE350069T1 (de) Potenziertes und stabilisiertes desinfektionsmittel mit bakterizider und viruzider wirkung
UA44086A (uk) Спосіб нейтралізації кислих смол

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties